Skip to main content

Advertisement

Log in

Chronic Cluster Headache Update and East–West Comparisons: Focusing on Clinical Features, Pathophysiology, and Management

  • Chronic Daily Headache (SJ Wang, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review provides an update on chronic cluster headache (CH) focusing on clinical features, pathophysiology, and management as well as comparisons between Eastern and Western populations.

Recent Findings

Chronic CH in Eastern populations was relatively rare, compared to that in Western populations. Lacrimation and/or conjunctival injection is the most frequently reported cranial autonomic symptom, and visual aura is predominant in chronic CH patients. Neuroimaging evidence in both ethnic groups suggests that CH pathophysiology involves the hypothalamus and pain-modulatory areas, with dynamic alternations between CH episodes. Recent evidence indicates that midbrain dopaminergic systems may participate in CH chronicity. Noteworthy advances have emerged in neuromodulatory therapies for chronic CH, but treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies has been unsuccessful.

Summary

Recent evidence shows divergence of chronic CH between Eastern and Western populations. Neuromodulatory therapies but not CGRP inhibition is effective in this intractable patient group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia [Internet]. 2018;38:1–211. https://doi.org/10.1177/0333102417738202 Available from:.

    Article  Google Scholar 

  2. Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden*. Headache J Head Face Pain [Internet]. 2012;52:99–113 Available from: https://headachejournal.onlinelibrary.wiley.com/doi/abs/10.1111/j.1526-4610.2011.02028.x.

  3. Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia [Internet]. 1987;7:76–8. Available from:. https://doi.org/10.1177/03331024870070S623.

    Article  Google Scholar 

  4. Wilbrink LA, Teernstra OPM, Haan J, van Zwet EW, Evers SMAA, Spincemaille GH, et al. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia [Internet]. 2013;33:1238–47. Available from:. https://doi.org/10.1177/0333102413490351.

    Article  Google Scholar 

  5. Steinberg A, Fourier C, Ran C, Waldenlind E, Sjo C, Belin AC. Cluster headache – clinical pattern and a new severity scale in a Swedish cohort 2018;38:1286–95. https://doi.org/10.1177/0333102417731773

  6. Torelli P, Beghi E, Manzoni GC. Cluster headache prevalence in the Italian general population. Neurology. 2005;64:469–74.

    Google Scholar 

  7. Ekbom K, Svensson DA, Pedersen NL, Waldenlind E. Lifetime prevalence and concordance risk of cluster headache in the Swedish twin population. Neurology. 2006;67:798–803.

    Google Scholar 

  8. Donnet A, Lanteri-Minet M, Guegan-Massardier E, Mick G, Fabre N, Géraud G, et al. Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry. 2007;78:1354–8.

    CAS  Google Scholar 

  9. Manzoni GC, Taga A, Russo M, Torelli P. Age of onset of episodic and chronic cluster headache – a review of a large case series from a single headache centre. J Headache Pain. 2016;17:4–9.

    Google Scholar 

  10. Dong Z, Di H, Dai W, Pan M, Li Z, Liang J, et al. Clinical profile of cluster headaches in China - a clinic-based study. J Headache Pain. 2013;14:1–10.

    Google Scholar 

  11. Imai N, Yagi N, Kuroda R, Konishi T, Serizawa M, Kobari M. Clinical profile of cluster headaches in Japan: low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. Cephalalgia. 2011;31:628–33.

    Google Scholar 

  12. Lin KH, Wang PJ, Fuh JL, Lu SR, Chung CT, Tsou HK, et al. Cluster headache in the Taiwanese - a clinic-based study. Cephalalgia. 2004;24:631–8.

    Google Scholar 

  13. Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A. Cluster headache--course over ten years in 189 patients. Cephalalgia. 1991;11:169–74.

    CAS  Google Scholar 

  14. Schürks M, Kurth T, De Jesus J, Jonjic M, Rosskopf D, Diener HC. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006;46:1246–54.

    Google Scholar 

  15. Diamond S, Urban G. Cluster headache. Pain Manag. 2006;1:474–91.

    Google Scholar 

  16. Association AM. Family history of cluster headache: a systematic review. 2020;77030. https://doi.org/10.1001/jamaneurol.2020.0682

  17. • Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality. 2011. An important review of CH and comorbidities in the US. https://doi.org/10.1111/j.1526-4610.2011.02028.x

  18. Bhargava A, Pujar GS, Banakar BF, Shubhakaran K, Kasundra G, Bhushan B. Study of cluster headache: a hospital-based study. J Neurosci Rural Pract. 2014;5:369–73.

    Google Scholar 

  19. Moon HS, Park JW, Lee KS, Chung CS, Kim BK, Kim JM, et al. Clinical features of cluster headache patients in Korea. J Korean Med Sci. 2017;32:502–6.

    Google Scholar 

  20. Gaul C, Christmann N, Schröder D, Weber R, Shanib H, Diener HC, et al. Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headache. Cephalalgia. 2012;32:571–7.

    CAS  Google Scholar 

  21. Robbins MS, Bronheim R, Lipton RB, Grosberg BM, Vollbracht S, Sheftell FD, et al. Depression and anxiety in episodic and chronic cluster headache: a pilot study. Headache. 2012;52:600–11.

    Google Scholar 

  22. Liang JF, Chen YT, Fuh JL, Li SY, Liu CJ, Chen TJ, et al. Cluster headache is associated with an increased risk of depression: a nationwide population-based cohort study. Cephalalgia. 2013;33:182–9.

    Google Scholar 

  23. • May A, Ashburner J, Büchel C, McGonigle DJ, Friston KJ, Frackowiak RS, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med United States. 1999;5:836–8 The first description of changes in gray matter volume within the bilateral posterior hypothalamus in CH patients using voxel-based morphometry, which correlated functional alterations in the same area during acute CH attacks.

    CAS  Google Scholar 

  24. Absinta M, Rocca MA, Colombo B, Falini A, Comi G, Filippi M. Selective decreased grey matter volume of the pain-matrix network in cluster headache. Cephalalgia England. 2012;32:109–15.

    Google Scholar 

  25. Yang F-C, Chou K-H, Fuh J-L, Huang C-C, Lirng J-F, Lin Y-Y, et al. Altered gray matter volume in the frontal pain modulation network in patients with cluster headache. Pain United States. 2013;154:801–7.

    Google Scholar 

  26. Naegel S, Holle D, Desmarattes N, Theysohn N, Diener H-C, Katsarava Z, et al. Cortical plasticity in episodic and chronic cluster headache. NeuroImage Clin. 2014;6:415–23.

    Google Scholar 

  27. • Arkink EB, Schmitz N, Schoonman GG, van Vliet JA, Haan J, van Buchem MA, et al. The anterior hypothalamus in cluster headache. Cephalalgia England. 2017;37:1039–50 Description of increased gray matter volume of the anterior hypothalamus in episodic and chronic CH patients compared to healthy controls.

    Google Scholar 

  28. Szabó N, Kincses ZT, Párdutz Á, Tóth E, Szok D, Csete G, et al. White matter disintegration in cluster headache. J Headache Pain. 2013;14:64.

    Google Scholar 

  29. Király A, Szabó N, Párdutz Á, Tóth E, Tajti J, Csete G, et al. Macro- and microstructural alterations of the subcortical structures in episodic cluster headache. Cephalalgia England. 2018;38:662–73.

    Google Scholar 

  30. Chou K-H, Yang F-C, Fuh J-L, Huang C-C, Lirng J-F, Lin Y-Y, et al. Altered white matter microstructural connectivity in cluster headaches: a longitudinal diffusion tensor imaging study. Cephalalgia [Internet]. 2014;34:1040–52. Available from. https://doi.org/10.1177/0333102414527649.

    Article  Google Scholar 

  31. Buture A, Boland JW, Dikomitis L, Ahmed F. Update on the pathophysiology of cluster headache: imaging and neuropeptide studies. J Pain Res. 2019;12:269–81.

    CAS  Google Scholar 

  32. Hsieh JC, Hannerz J, Ingvar M. Right-lateralised central processing for pain of nitroglycerin-induced cluster headache. Pain. 1996;67:59–68.

    CAS  Google Scholar 

  33. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet (London, England). 1998;352:275–8.

    CAS  Google Scholar 

  34. Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology United States. 2004;62:516–7.

    CAS  Google Scholar 

  35. Sprenger T, Ruether KV, Boecker H, Valet M, Berthele A, Pfaffenrath V, et al. Altered metabolism in frontal brain circuits in cluster headache. Cephalalgia. England. 2007;27:1033–42.

    CAS  Google Scholar 

  36. Morelli N, Pesaresi I, Cafforio G, Maluccio MR, Gori S, Di Salle F, et al. Functional magnetic resonance imaging in episodic cluster headache. J Headache Pain. 2009;10:11–4.

    Google Scholar 

  37. Rocca MA, Valsasina P, Absinta M, Colombo B, Barcella V, Falini A, et al. Central nervous system dysregulation extends beyond the pain-matrix network in cluster headache. Cephalalgia England. 2010;30:1383–91.

    Google Scholar 

  38. Yang F-C, Chou K-H, Fuh J-L, Lee P-L, Lirng J-F, Lin Y-Y, et al. Altered hypothalamic functional connectivity in cluster headache: a longitudinal resting-state functional MRI study. J Neurol Neurosurg Psychiatry England. 2015;86:437–45.

    Google Scholar 

  39. Chou K-H, Yang F-C, Fuh J-L, Kuo C-Y, Wang Y-H, Lirng J-F, et al. Bout-associated intrinsic functional network changes in cluster headache: a longitudinal resting-state functional MRI study. Cephalalgia England. 2017;37:1152–63.

    Google Scholar 

  40. Qiu E, Tian L, Wang Y, Ma L, Yu S. Abnormal coactivation of the hypothalamus and salience network in patients with cluster headache. Neurology United States. 2015;84:1402–8.

    Google Scholar 

  41. • Ferraro S, Nigri A, Bruzzone MG, Brivio L, Proietti Cecchini A, Verri M, et al. Defective functional connectivity between posterior hypothalamus and regions of the diencephalic-mesencephalic junction in chronic cluster headache. Cephalalgia England. 2018;38:1910–8 A recent RS-fMRI trial suggested that midbrain dopaminergic systems could play a role in CH pathophysiology, particulalry in its chronicity.

    Google Scholar 

  42. • Fanciullacci M, Alessandri M, Sicuteri R, Marabini S. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain England. 1997;120(Pt 2):283–8 Description of activation of the trigeminovascular system occuring only in patients actively experiencing a CH bout, who also have high basal CGRP-like immunoreactivity plasma levels. This suggests a hyperactivity of trigeminal nociceptive fibers making the trigeminovascular system of these patients sensitive to the triggering action of nitroglycerine.

    Google Scholar 

  43. Riesco N, Cernuda-Morollón E, Martínez-Camblor P, Pérez-Alvarez AI, Verano L, García-Cabo C, et al. Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: a study in chronic migraine patients. Cephalalgia England. 2017;37:823–7.

    CAS  Google Scholar 

  44. Tuka B, Szabó N, Tóth E, Kincses ZT, Párdutz Á, Szok D, et al. Release of PACAP-38 in episodic cluster headache patients - an exploratory study. J Headache Pain. 2016;17:69.

    Google Scholar 

  45. Di Sabato F, Giacovazzo M, Cristalli G, Rocco M, Fusco BM. Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients. Headache United States. 1996;36:221–3.

    Google Scholar 

  46. Samsam M, Coveñas R, Ahangari R, Yajeya J, Narváez JA, Tramu G. Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion. Pain United States. 2000;84:389–95.

    CAS  Google Scholar 

  47. D’Amico D, Leone M, Ferraris A, Catania A, Carlin A, Grazzi L, et al. Role of nitric oxide in cluster headache. Ital J Neurol Sci Italy. 1999;20:S25–7.

    Google Scholar 

  48. Martins-Oliveira M, Akerman S, Tavares I, Goadsby PJ. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine. Pain. 2016;157:1666–73.

    Google Scholar 

  49. May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol England. 2006;13:1066–77.

    CAS  Google Scholar 

  50. Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache United States. 2016;56:1093–106.

    Google Scholar 

  51. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA United States. 2009;302:2451–7.

    CAS  Google Scholar 

  52. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol Scand. Denmark; 1993;88:63–69.

  53. Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group. N Engl J Med United States. 1991;325:322–6.

    Google Scholar 

  54. Ekbom K, Waldenlind E, Cole J, Pilgrim A, Kirkham A. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia England. 1992;12:254–6.

    CAS  Google Scholar 

  55. Kallweit U, Sándor PS. Sumatriptan in excessive doses over 15 years in a patient with chronic cluster headache. Headache United States. 2011;51:1546–8.

    Google Scholar 

  56. Leone M, Proietti CA. Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache. Neurology. 2016;86:194–5.

    Google Scholar 

  57. Magnoux E, Zlotnik G. Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache United States. 2004;44:249–55.

    CAS  Google Scholar 

  58. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol United States. 2004;56:488–94.

    CAS  Google Scholar 

  59. Brandt RB, Doesborg PGG, Haan J, Ferrari MD, Fronczek R. Pharmacotherapy for cluster headache. CNS Drugs [Internet]. 2020;34:171–84. Available from:. https://doi.org/10.1007/s40263-019-00696-2.

    Article  CAS  Google Scholar 

  60. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet [Internet] Elsevier. 2005;366:843–55. Available from:. https://doi.org/10.1016/S0140-6736(05)67217-0.

    Article  Google Scholar 

  61. Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache J Head Face Pain [Internet]. 1990;30:411–7 Available from: https://doi.org/10.1111/j.1526-4610.1990.hed3007411.x.

  62. Blau JN, Engel HO. Individualizing treatment with verapamil for cluster headache patients. Headache J Head Face Pain [Internet]. 2004;44:1013–8 Available from: https://doi.org/10.1111/j.1526-4610.2004.04196.x.

  63. Gabai IJ, Spierings ELH. Prophylactic treatment of cluster headache with verapamil. Headache J Head Face Pain [Internet]. 1989;29:167–8 Available from: https://doi.org/10.1111/j.1526-4610.1989.hed2903167.x.

  64. Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache J Head Face Pain [Internet]. 1981;21:132–9 Available from: https://doi.org/10.1111/j.1526-4610.1981.hed2104132.x.

  65. Ashkenazi A, Schwedt T. Cluster headache—acute and prophylactic therapy. Headache J Head Face Pain [Internet]. 2011;51:272–86 Available from: https://doi.org/10.1111/j.1526-4610.2010.01830.x.

  66. Láinez MJA, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A. Topiramate in the prophylactic treatment of cluster headache. Headache J Head Face Pain [Internet]. 2003;43:784–9 Available from: https://doi.org/10.1046/j.1526-4610.2003.03137.x.

  67. Leone M, Dodick D, Rigamonti A, D’Amico D, Grazzi L, Mea E, et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia [Internet]. 2003;23:1001–2. Available from:. https://doi.org/10.1046/j.1468-2982.2003.00665.x.

  68. Huang W, Lo M, Wang S, Tsai J, Wu H. Topiramate in prevention of cluster headache in the Taiwanese. Neurol India [Internet]. 2010;58:284–7 Available from: http://www.neurologyindia.com/article.asp?issn=0028-3886.

  69. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia [Internet]. 1989;9:195–8. Available from:. https://doi.org/10.1046/j.1468-2982.1989.0903195.x.

    Article  CAS  Google Scholar 

  70. Amrani M, El Massiou H, Bousser MG. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia [internet]. 2002;22:205–8. Available from:. https://doi.org/10.1046/j.1468-2982.2002.00349.x.

    Article  Google Scholar 

  71. Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia [Internet]. 1996;16:494–6. Available from:. https://doi.org/10.1046/j.1468-2982.1996.1607494.x.

    Article  CAS  Google Scholar 

  72. Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aubé M. Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache J Head Face Pain [Internet]. 2002;42:787–92 Available from: https://doi.org/10.1046/j.1526-4610.2002.02181.

  73. Peres MFP, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia [Internet]. 2001, 2001;21:993–5. Available from:. https://doi.org/10.1046/j.1468-2982.2001.00307.x.

  74. Leandri M, Luzzani M, Cruccu G, Gottlieb A. Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia [Internet]. 2001;21:744–6. Available from:. https://doi.org/10.1111/j.1468-2982.2001.00260.x.

    Article  CAS  Google Scholar 

  75. Schuh-Hofer S, Israel H, Neeb L, Reuter U, Arnold G. The use of gabapentin in chronic cluster headache patients refractory to first-line therapy. Eur J Neurol [Internet]. 2007;14:694–6 Available from:https://doi.org/10.1046/j.1526-4610.2002.02181.x.

  76. Sostak P, Krause P, Förderreuther S, Reinisch V, Straube A. Botulinum toxin type-A therapy in cluster headache: an open study. J Headache Pain [Internet]. 2007;8:236–41. Available from:. https://doi.org/10.1007/s10194-007-0400-0.

    Article  CAS  Google Scholar 

  77. D’Andrea G, Perini F, Granella F, Cananzi A, Sergi A. Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study. Cephalalgia [Internet]. 1995;15:430–3. Available from:. https://doi.org/10.1046/j.1468-2982.1995.1505430.x.

    Article  Google Scholar 

  78. Sicuteri F, Fusco BM, Marabini S, Campagnolo V, Maggi CA, Geppetti P, et al. Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain [Internet]. 1989;5 Available from:https://doi.org/10.1097/00002508-198903000-00010.

  79. Fusco BM, Marabini S, Maggi CA, Fiore G, Geppetti P. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain [Internet]. 1994;59 Available from:https://doi.org/10.1016/0304-3959(94)90017-5.

  80. Marks DR, Rapoport A, Padla D, Weeks R, Rosum R, Sheftell F, et al. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia [Internet]. 1993;13:114–6. Available from:. https://doi.org/10.1046/j.1468-2982.1993.1302114.x.

    Article  CAS  Google Scholar 

  81. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia [Internet]. 1993;13:309–17. Available from:. https://doi.org/10.1046/j.1468-2982.1993.1305309.x.

    Article  CAS  Google Scholar 

  82. Rozen T. Clomiphene citrate for treatment refractory chronic cluster headache. Headache J Head Face Pain [Internet]. 2008;48:286–90 Available from:https://doi.org/10.1111/j.1526-4610.2007.00995.x.

  83. Rozen TD. Clomiphene citrate as a preventive treatment for intractable chronic cluster headache: a second reported case with long-term follow-up. Headache J Head Face Pain [Internet]. 2015;55:571–4 Available from:https://doi.org/10.1111/head.12491.

  84. Nobre ME, Peres MFP, Moreira Filho PF, Leal AJ. Clomiphene treatment may be effective in refractory episodic and chronic cluster headache. Arq Neuropsiquiatr [Internet]. 2017;75:620–4 scielo; Available from:https://doi.org/10.1590/0004-282X20170119.

  85. D’Arrigo G, Di Fiore P, Galli A, Frediani F. High dosage of methylprednisolone in cluster headache. Neurol Sci [Internet]. 2018;39:157–8. https://doi.org/10.1007/s10072-018-3383-5 Available from:.

    Article  Google Scholar 

  86. Siow HC, Pozo-Rosich P, Silberstein SD. Frovatriptan for the treatment of cluster headaches. Cephalalgia [Internet] SAGE Publications Ltd STM. 2004;24:1045–8. Available from:. https://doi.org/10.1111/j.1468-2982.2004.00734.x.

    Article  CAS  Google Scholar 

  87. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes – prolonged effects from a single injection. Pain [Internet]. 2006;122 Available from: https://doi.org/10.1016/j.pain.2006.01.016.

  88. Gantenbein AR, Lutz NJ, Riederer F, Sándor PS. Efficacy and safety of 121 injections of the greater occipital nerve in episodic and chronic cluster headache. Cephalalgia [Internet]. 2012, 2012;32:630–4. Available from:. https://doi.org/10.1177/0333102412443335.

  89. Lambru G, Abu Bakar N, Stahlhut L, McCulloch S, Miller S, Shanahan P, et al. Greater occipital nerve blocks in chronic cluster headache: a prospective open-label study. Eur J Neurol [Internet]. 2014;21:338–43 Available from:https://doi.org/10.1111/ene.12321.

  90. Gaul C, Roguski J, Dresler T, Abbas H, Totzeck A, Görlinger K, et al. Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: a prospective observational study. Cephalalgia [Internet]. 2017;37:873–80. Available from:. https://doi.org/10.1177/0333102416654886.

    Article  Google Scholar 

  91. Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005;118(1-2):92–6 Available from: https://doi.org/10.1016/j.pain.2005.07.015.

  92. • Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol [Internet] Elsevier. 2011;10:891–7. https://doi.org/10.1016/S1474-4422(11)70186-7 Available from. A randomised, double-blind, and placebo-controlled trial concluded that suboccipital steroid injections can relieve CH rapidly in patients having frequent daily attacks, irrespective of type (chronic or episodic).

    Article  CAS  Google Scholar 

  93. Lantéri-Minet M, Fontaine D, Magis D. In: Leone M, May A, editors. Neurostimulation: why, when, and which one? BT - cluster headache and other trigeminal autonomic cephalgias. Cham: Springer International Publishing; 2020. p. 153–67. Available from:. https://doi.org/10.1007/978-3-030-12438-0_13.

    Chapter  Google Scholar 

  94. • Gaul C, Diener H-C, Silver N, Magis D, Reuter U, Andersson A, et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia [Internet]. 2016;36:534–46. https://doi.org/10.1177/0333102415607070 Available from. A prospective, multicenter, open-label, and randomized study concluded that adjunctive prophylactic nVNS is a well-tolerated novel treatment for chronic CH, offering clinical benefits beyond standard of care.

    Article  Google Scholar 

  95. Martelletti P, Jensen RH, Antal A, Arcioni R, Brighina F, de Tommaso M, et al. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain [Internet]. 2013;14:86. Available from:. https://doi.org/10.1186/1129-2377-14-86.

    Article  Google Scholar 

  96. Aibar-Durán JÁ, Holzapfel MJÁ, Rodríguez RR, Nieto RB, Arnall CR, Teixido JM. Occipital nerve stimulation and deep brain stimulation for refractory cluster headache: a prospective analysis of efficacy over time. J Neurosurg JNS American Association of Neurological Surgeons. 2020;Jan 17:1–8.

    Google Scholar 

  97. Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJA, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33:816–30.

    Google Scholar 

  98. • Jürgens TP, Barloese M, May A, Láinez JM, Schoenen J, Gaul C, et al. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia. 2017;37:423–34 An analysis providing support for the use of SPG stimulation for disabled patients and in those who are treatment-resistant or who have had poor outcomes with first-line treatments.

    Google Scholar 

  99. Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain United States. 1995;60:119–23.

    CAS  Google Scholar 

  100. Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, et al. Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial. JAMA Neurol. 2018;75:1187–97.

    Google Scholar 

Download references

Funding

This project was supported in part by grants from the Ministry of Science and Technology of Taiwan (MOST 108-2314-B-016-023-) and TSGH (TSGH-C108-100, TSGH-D-109101, TSGH-D-109185).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Fu-Chi Yang or Shuu-Jiun Wang.

Ethics declarations

Conflict of Interest

Chia-Lin Tsai, Guan-Yu Lin, Sheng-Kai Wu, Fu-Chi Yang, and Shuu-Jiun Wang declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Chronic Daily Headache

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsai, CL., Lin, GY., Wu, SK. et al. Chronic Cluster Headache Update and East–West Comparisons: Focusing on Clinical Features, Pathophysiology, and Management. Curr Pain Headache Rep 24, 68 (2020). https://doi.org/10.1007/s11916-020-00902-7

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11916-020-00902-7

Keywords

Navigation